Compass Therapeutics, Inc. (CMPX)

NASDAQ: CMPX · Real-Time Price · USD

0.7738

-0.0462 (-5.63%)

At close: Nov 13, 2026, 4:00 PM EST

0.7678

-0.0060 (-0.78%)

After-hours: Nov 13, 2026, 7:18 PM EST

Compass Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	41.47	30.64	43.48	24.23	34.95	144.51
Short-Term Investments	121.59	178.26	83.24	128.23	151.66	-
Cash & Short-Term Investments	163.06	208.91	126.72	152.46	186.61	144.51
Cash Growth	-25.85%	64.85%	-16.88%	-18.30%	29.13%	206.98%
Prepaid Expenses	2.44	0.91	6.03	1.42	8.18	2.59
Total Current Assets	165.5	209.82	132.75	153.88	194.79	147.11
Property, Plant & Equipment	8.43	9.2	7.08	2.67	4.53	6.33
Other Long-Term Assets	0.57	0.57	0.57	0.32	0.32	0.32
Total Assets	174.5	219.59	140.4	156.88	199.65	153.76

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	6.32	1.59	2.25	4.09	3.38	0.87
Accrued Expenses	16.38	11.38	6.29	2.51	11.69	8.78
Current Portion of Leases	1.67	1	0.34	1.2	1.1	0.99
Total Current Liabilities	24.37	13.97	8.87	7.8	16.17	10.63
Long-Term Leases	7.56	8.83	6.3	0.54	1.84	3.05
Total Liabilities	31.93	22.8	15.17	8.34	18.01	13.68

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.02	0.02	0.01	0.01	0.01	0.01
Additional Paid-In Capital	644.93	627.67	489.69	463.8	454.74	373.66
Retained Earnings	-501.81	-431.17	-364.68	-315.31	-272.81	-233.59
Comprehensive Income & Other	-0.57	0.28	0.21	0.04	-0.3	-
Total Common Equity	142.57	196.79	125.23	148.54	181.64	140.08
Shareholders' Equity	142.57	196.79	125.23	148.54	181.64	140.08
Total Liabilities & Equity	174.5	219.59	140.4	156.88	199.65	153.76

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	9.23	9.83	6.63	1.73	2.94	4.04
Net Cash (Debt)	153.82	199.08	120.09	150.73	183.67	140.48
Net Cash Growth	-26.76%	65.78%	-20.33%	-17.94%	30.75%	272.20%
Net Cash Per Share	0.83	1.26	0.87	1.19	1.75	2.23
Filing Date Shares Outstanding	180.09	180.09	138.28	137.59	126.31	100.83
Total Common Shares Outstanding	180.09	178.32	137.82	127.67	126.3	100.83
Working Capital	141.13	195.85	123.88	146.08	178.62	136.47
Book Value Per Share	0.79	1.10	0.91	1.16	1.44	1.39
Tangible Book Value	142.57	196.79	125.23	148.54	181.64	140.08
Tangible Book Value Per Share	0.79	1.10	0.91	1.16	1.44	1.39
Machinery	5.04	4.76	4.74	5.19	5.16	5.37
Leasehold Improvements	1.61	1.61	1.61	1.61	1.61	1.53

SEC Filings: 10-K · 10-Q